Poolbeg Pharma to Participate in Key Conferences in September 2026
Poolbeg Pharma, a clinical-stage biopharmaceutical company with a core focus on transforming the cancer immunotherapy field, announces that it has been selected to present at a number of leading international conferences this September.
All-Ireland Clinical AI Congress & AI Tech Expo
A new national healthcare conference dedicated to the practical adoption of artificial intelligence across the Irish healthcare system.
Title: AI in Drug Development: A Practical Case Study from an Industry Perspective
Presenter: Liam Tremble, Principal Scientist
Date & time: 12 September 2026, 11:15am BST
Location: O'Reilly Hall at University College Dublin, Belfield, Dublin 4
28th Annual H.C. Wainwright Global Investment Conference
A leading investor conference bringing together public and private companies, institutional investors and industry leaders for corporate presentations, one-on-one meetings and networking opportunities.
Presenters: Jeremy Skillington, PhD, Chief Executive Officer and Ian O'Connell, Chief Financial Officer
Date & time: The presentation will be available on demand from 11 September 2026, 7:00am EST / 12:00pm BST
Location: Lotte New York Palace Hotel in New York
Meetings: Management will be available at the conference in New York for in-person one-on-one meetings with investors on 14-16 September 2026. To schedule a meeting, investors should contact their H.C. Wainwright representative or contact Poolbeg directly at [email protected].
BIOShanghai Week 2026
BIOShanghai Week is a leading life sciences and biotechnology conference in China, bringing together global biopharma leaders, investors and innovators to explore industry trends, scientific advances and opportunities for collaboration and partnering.
Presentation title: From China to Europe: Raglan Capital - Sharing Experience, Building Partnerships in Biotech
Presenter: Cathal Friel, Executive Chair
Date & time: 18 September 2026
Location: Zhangjiang Science Hall, Pudong New Area, Shanghai, China
Investor Summit 2026
A leading UK investment conference bringing together 450+ private investors, CEOs, fund managers and finance professionals for a full day of expert insights, company presentations, panel discussions and networking.
Panel title: The Importance of Partnering to the Pharmaceutical Industry: The POLB 001 Opportunity
Panellists: Jeremy Skillington, PhD (CEO, Poolbeg Pharma), Chris Grimes-Crompton (Partner, Global Value and Access, Acumetis Global) & Michiel Bröker (Global Head of Pharma / Healthcare EMEA, UBS)
Moderated by: Ed Bowsher (Freelance journalist and investor)
Date & time: 18 September 2026, 13:40pm BST
Location: Upper Sugar Track, The Brewery, Chiswell Street, London, EC1Y 4SA
International Myeloma Society Annual Meeting
The International Myeloma Society Meeting is the premier global scientific conference in myeloma with a focus on basic, preclinical, and clinical aspects of disease. It brings together leading clinicians, academics, and pharmaceutical representatives to tackle the most pressing challenges in myeloma.
Poster title: POLB 001, an oral p38 MAPK inhibitor for the prevention of cytokine release syndrome
Presenter: Liam Tremble, Principal Scientist
Date & time: 24 September 2026, 12.00 - 13.00pm BST
Session: Session 1: Plenary. Global and National Perspectives on AI in Healthcare
Location: Scottish Events Campus, Glasgow, Scotland
If you would like to meet the Poolbeg team at any of the above events, please contact us at [email protected].
